Transaction in Own Shares

RNS Number : 9225D
HSBC Holdings PLC
07 March 2022
 

 

HSBC HOLDINGS PLC

7 March 2022

Transaction in own shares

 

HSBC Holdings plc (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of US$0.50 from Morgan Stanley & Co. International plc ("Morgan Stanley") as part of its buy-back announced on 26 October 2021.

 

Date of purchase:

7 March 2022

Number of ordinary shares of US$0.50 each purchased:

9,745,202

Highest price paid per share:

£4.7485

Lowest price paid per share:

£4.4935

Volume weighted average price paid per share:

£4.6515

 

 

All repurchases by the Company are "on Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and "on market" for the purposes of the Companies Act 2006.

Following the cancellation of the repurchased shares, the Company will have 20,542,688,536 ordinary shares in issue, including 325,273,407 ordinary shares which are held in treasury. Therefore the total voting rights in the Company will be 20,217,415,129. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, a full breakdown of the individual trades made by Morgan Stanley on behalf of the Company is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/9225D_1-2022-3-7.pdf

This announcement will also be available on HSBC's website at www.hsbc.com/sea 

Enquiries to:

Lee Davis

Corporate Governance & Secretariat

+44 (0) 207 991 3048

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBKOBPABKDFNK
UK 100

Latest directors dealings